Clinical Trials in Florida

Showing 4641-4660 of 12,796 trials

Oral Nutritional Supplementation in Children at Risk of Undernutrition

NCT05161000

The objective of this randomized, controlled trial is to evaluate the effects of consuming a pediatric oral nutritional supplement (ONS) plus dietary counseling for 120 days on anthropometric growth, strength, and nutritional status, compared with dietary counseling alone in undernourished children in the United States.

Undernutrition

Abbott Nutrition279 participantsStarted Apr 2022

Oneonta, Alabama, United States • Glenwood, Arkansas, United States • Hot Springs, Arkansas, United States +14 more locations

TERMINATEDPhase 344 miles

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

NCT02914600

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior filgotinib treatment study in Crohn's disease (CD).

Crohn's Disease

Galapagos NV1,188 participantsStarted Mar 2017

Dothan, Alabama, United States • Sun City, Arizona, United States • Coronado, California, United States +483 more locations

Oral Nutritional Supplementation in Children at Risk of Undernutrition

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Find Trials by Condition in Florida

Belimumab Assessment of Safety in SLE

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)

A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop

Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medical Management

Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

C-myc Biomarker Study for Diabetic Foot Ulcers

Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)

Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients

Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Predictors of Intracranial Atherosclerotic Disease in Posterior Circulation: a Cohort Study

Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma